Peringkat dalam Saham
#27274
Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on... Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on pioneering the discovery and development of therapeutic solutions for long-term inflammatory conditions. The company's primary therapeutic asset, SOL-116, is a humanized antibody currently in the late preclinical stage, designed to treat pediatric rheumatism and adult rheumatoid arthritis. To facilitate the advancement of SOL-116 into clinical trials, Lipum has established a collaboration with Pelago Bioscience AB to meticulously monitor drug targets. Founded in 2010, the company's operations are headquartered in Umeå, Sweden.
Harga Saham
$1.60
Terakhir disinkronkan: 2026-03-18
Kapitalisasi Pasar
$34.00M
Perubahan (1 tahun)
2.50%
Perdagangan Lipum AB (publ) (LIPUM)
Harga LIPUM dengan kapitalisasi pasar B
Kapitalisasi pasar dari Lipum AB (publ)(LIPUM)
Kapitalisasi Pasar: $34.00M
Per August 2026, Lipum AB (publ) memiliki kapitalisasi pasar sebesar $34.00M. Ini menjadikan Lipum AB (publ) sebagai perusahaan 27274th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Lipum AB (publ) dari 2021 hingga 2026
LIPUM dibandingkan dengan 5 teratas stocks paling populer
| Harga LIPUM |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.301T
|
+15,589,977.50%
|
|
|
|
|
$4.634T
|
+13,628,302.52%
|
|
|
|
|
$4.143T
|
+12,184,582.16%
|
|
|
|
|
$3.589T
|
+10,556,397.47%
|
|
|
|
|
$2.857T
|
+8,402,307.07%
|
